scispace - formally typeset
T

Tonghai Zhang

Researcher at Eli Lilly and Company

Publications -  8
Citations -  417

Tonghai Zhang is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: T cell & Sepsis. The author has an hindex of 7, co-authored 8 publications receiving 397 citations.

Papers
More filters
Journal ArticleDOI

Adoptive Transfer of In Vitro-Stimulated CD4+CD25+ Regulatory T Cells Increases Bacterial Clearance and Improves Survival in Polymicrobial Sepsis

TL;DR: Adoptive transfer of in vitro-stimulated Tregs in both prevention and therapeutic modes significantly improved survival of cecal ligation and puncture mice and suggest a novel role for T Regs in sepsis.
Journal ArticleDOI

FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis.

TL;DR: FGF21 is a positive APR protein that protects animals from the toxic effects of LPS and sepsis, and treatment with exogenous FGF21 reduced the number of animals that die and the rapidity of death after LPS administration in leptin-deficient ob/ob mice and to a lesser extent in control mice.
Journal ArticleDOI

Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis.

TL;DR: The data from this study indicate that an early decrease in protein C concentration predicts poor outcome in a rat sepsis model and indicates that increases in the CXC chemokines macrophage inflammatory protein-2 and KC precede poor outcome.
Journal ArticleDOI

Enhanced B Cell Expansion, Survival, and Humoral Responses by Targeting Death Receptor 6

TL;DR: This is the first demonstration of a regulatory role of DR6 in the activation and function of B cells in the presence of T-dependent as well as T-independent type I and II antigens.
Journal ArticleDOI

Cecal ligation and puncture with total parenteral nutrition: a clinically relevant model of the metabolic, hormonal, and inflammatory dysfunction associated with critical illness.

TL;DR: The results indicate that addition of TPN to CLP provides a clinically relevant animal model of critical illness with associated hyperglycemia that may provide utility for the testing of glucoregulatory and other therapeutic modalities.